Clinical Neuroscience and Entertainment Software Pilot Partnership Program to Develop Neuropsychiatric Interventions (R43/R44)
The summary for the Clinical Neuroscience and Entertainment Software Pilot Partnership Program to Develop Neuropsychiatric Interventions (R43/R44) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Clinical Neuroscience and Entertainment Software Pilot Partnership Program to Develop Neuropsychiatric Interventions (R43/R44): This Funding Opportunity Announcement (FOA) utilizes the Small Business Innovation Research Program (SBIR) award mechanism to support the development of highly engaging cognitive training interventions delivered through computers and/or gaming platforms that are targeted to the treatment of neuropsychiatric disorders, autism and/or HIV Associated Neurocognitive Disorders (HAND), with the goal of improving real-world functioning of patients. This initiative specifically supports small businesses with development and commercial experience in the entertainment software industry to partner with clinical neuroscientists experienced with cognitive training.
| Federal Grant Title: | Clinical Neuroscience and Entertainment Software Pilot Partnership Program to Develop Neuropsychiatric Interventions (R43/R44) |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-MH-14-010 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.242 |
| CFDA Descriptions: | Mental Health Research Grants |
| Current Application Deadline: | Apr 10, 2013 |
| Original Application Deadline: | Apr 10, 2013 |
| Posted Date: | Jan 16, 2013 |
| Creation Date: | Jan 16, 2013 |
| Archive Date: | May 11, 2013 |
| Total Program Funding: | $3,000,000 |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Small businesses
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Advancing Research on Empirically-Supported Interventions for Older Adults Living with Ser...
- • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...
- • Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Re...
- • Single Source: Accelerating Medicines Partnership Schizophrenia (AMP SCZ): Data Processing...
- • Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowe...
- • Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R4...
- • Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44...
- • Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
- More Grants from the National Institutes of Health
- • NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clini...
- • NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not All...
- • Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Ad...
- • Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial N...
- • Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Ad...
